As of August 2025, nearly 12% of Americans have used GLP-1 drugs for weight loss, including about one-fifth of women aged 50 to 64
It is safe to take this drug, so long as it is taken orally, with or without food and therefore reducing instances of stomach upset
Most patients begin to notice weight loss within the first 14 weeks of starting semaglutide, especially once lifestyle changes like improved diet are incorporated
This mechanistic advantage reflects tirzepatide's broader impact on multiple metabolic control centers, offering context for why some patients experience more robust appetite suppression
Both product lines offer ultra-moisturizing benefits, but with different star ingredients
doi: 10.1210/jc.2017-01210 52 HjelholtAJCharidemouEGriffinJLPedersenSBGudiksenAPilegaardHet al